Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Y Feng

Showing results (81-90 of 459) with videos related to

Pageof 46
Sort By:
Neoplasia (New York, N.Y.)|March 8, 2020
Neddylation inactivation represses androgen receptor transcription and inhibits growth, survival and invasion of prostate cancer cellsXiaochen Zhou, Sumin Han, Kari Wilder-Romans, et al.
Prostate Cancer and Prostatic Diseases|March 25, 2023
Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern eraTing Martin Ma, Felix Y Feng, Seth A Rosenthal, et al.
Cancer Research Communications|December 23, 2022
IL-1β expression driven by androgen receptor absence or inactivation promotes prostate cancer bone metastasisAnthony DiNatale, Asurayya Worrede, Waleed Iqbal, et al.
Urology|July 6, 2015
Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and UrologistsPaul L Nguyen, Heesun Shin, Kasra Yousefi, et al.
Practical Radiation Oncology|June 4, 2014
Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapyWilliam C Jackson, Skyler B Johnson, Benjamin Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivoFelix Y Feng, Carlos A Lopez, Daniel P Normolle, et al.
Journal of the National Cancer Institute|October 7, 2016
Development of a RNA-Seq Based Prognostic Signature in Lung AdenocarcinomaSudhanshu Shukla, Joseph R Evans, Rohit Malik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2023
Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of DeathDerya Tilki, Ming-Hui Chen, Jing Wu, et al.
Neoplasia (New York, N.Y.)|April 25, 2016
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent MannerFelix Y Feng, Yu Zhang, Vishal Kothari, et al.
European Urology|January 27, 2019
Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason ScoresBrandon A Mahal, Mohammed Alshalalfa, Daniel E Spratt, et al.
Pageof 46

Showing results (81-90 of 459) with videos related to

Sort By:
Pageof 46
Neoplasia (New York, N.Y.)|March 8, 2020
Neddylation inactivation represses androgen receptor transcription and inhibits growth, survival and invasion of prostate cancer cellsXiaochen Zhou, Sumin Han, Kari Wilder-Romans, et al.
Prostate Cancer and Prostatic Diseases|March 25, 2023
Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern eraTing Martin Ma, Felix Y Feng, Seth A Rosenthal, et al.
Cancer Research Communications|December 23, 2022
IL-1β expression driven by androgen receptor absence or inactivation promotes prostate cancer bone metastasisAnthony DiNatale, Asurayya Worrede, Waleed Iqbal, et al.
Urology|July 6, 2015
Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and UrologistsPaul L Nguyen, Heesun Shin, Kasra Yousefi, et al.
Practical Radiation Oncology|June 4, 2014
Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapyWilliam C Jackson, Skyler B Johnson, Benjamin Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivoFelix Y Feng, Carlos A Lopez, Daniel P Normolle, et al.
Journal of the National Cancer Institute|October 7, 2016
Development of a RNA-Seq Based Prognostic Signature in Lung AdenocarcinomaSudhanshu Shukla, Joseph R Evans, Rohit Malik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2023
Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of DeathDerya Tilki, Ming-Hui Chen, Jing Wu, et al.
Neoplasia (New York, N.Y.)|April 25, 2016
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent MannerFelix Y Feng, Yu Zhang, Vishal Kothari, et al.
European Urology|January 27, 2019
Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason ScoresBrandon A Mahal, Mohammed Alshalalfa, Daniel E Spratt, et al.
Pageof 46